Joint Formulary & PAD

RESPeRATE - Hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Device
Associated Icons :
Guidelines
NFD1
Restrictions / Comments :
Important

This device has not been agreed for inclusion on the formulary. Primary Care must not be asked to prescribe until a place in therapy has been agreed by the APC. Contact your pharmacy / medicines optimisation team for advice.

Documentation

PAD Profile

ChemicalSubstance :
RESPeRATE
Indication :
Hypertension
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (0)

  • No records returned.